Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Shibang Guo, Yibo Zhang, Zhankui Liu, Daozhong Wang, Hui Liu, Liang Li, Qichao Chen, Dan Yang, Qingyun Liu, Huihui Guo, Shuang Mou, Huanchun Chen & Xiangru Wang. (2023) Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro. Emerging Microbes & Infections 12:2.
Read now
Read now
Madhusmita Rout, Suchanda Dey, Sarbani Mishra, Sunita Panda, Mahender Kumar Singh, Rohan Sinha, Budheswar Dehury & Sanghamitra Pati. (2023) Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Read now
Funanani Takalani, Pradeep Kumar, Pierre P. D. Kondiah, Yahya E. Choonara & Viness Pillay. (2020) Lipid–drug conjugates and associated carrier strategies for enhanced antiretroviral drug delivery. Pharmaceutical Development and Technology 25:3, pages 267-280.
Read now
Read now
Shellee A. Grim, Gail E. Reid & Nina M. Clark. (2017) Update in the treatment of non-influenza respiratory virus infection in solid organ transplant recipients. Expert Opinion on Pharmacotherapy 18:8, pages 767-779.
Read now
Read now
Reem S. Almaghrabi, Ali S. Omrani & Ziad A. Memish. (2017) Cytomegalovirus infection in lung transplant recipients. Expert Review of Respiratory Medicine 11:5, pages 377-383.
Read now
Read now
Raj Kumar Singh, Kuldeep Dhama, Yashpal Singh Malik, Muthannan Andavar Ramakrishnan, Kumaragurubaran Karthik, Rekha Khandia, Ruchi Tiwari, Ashok Munjal, Mani Saminathan, Swati Sachan, Perumal Arumugam Desingu, Jobin Jose Kattoor, Hafiz M.N. Iqbal & Sunil Kumar Joshi. (2017) Ebola virus – epidemiology, diagnosis, and control: threat to humans, lessons learnt, and preparedness plans – an update on its 40 year's journey. Veterinary Quarterly 37:1, pages 98-135.
Read now
Read now
Franco Locatelli, Alice Bertaina, Valentina Bertaina & Pietro Merli. (2016) Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection. Expert Review of Hematology 9:11, pages 1093-1105.
Read now
Read now
Maude Loignon & Emil Toma. (2016) Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions. Expert Review of Anti-infective Therapy 14:2, pages 177-191.
Read now
Read now
William SM Wold & Karoly Toth. (2015) New drug on the horizon for treating adenovirus. Expert Opinion on Pharmacotherapy 16:14, pages 2095-2099.
Read now
Read now
Articles from other publishers (92)
M.H. Yashavarddhan, Deepika Bohra, Rashmi Rana, Hardeep Singh Tuli, Vivek Ranjan, Devinder Singh Rana & Nirmal Kumar Ganguly. (2023) Comprehensive overview of 2022 human monkeypox outbreak and its pathology, prevention, and treatment: A strategy for disease control. Microbiological Research 277, pages 127504.
Crossref
Crossref
Brent Brown, Ingo Fricke, Chinua Imarogbe, Alexander Ariel Padrón González, Osvaldo Aguilera Batista, Pascal Mensah & Enrique Chacon-Cruz. (2023) Immunopathogenesis of Orthopoxviridae: insights into immunology from smallpox to monkeypox (mpox). Exploration of Immunology, pages 525-553.
Crossref
Crossref
Simone Cesaro. (2023) Adenovirus infection in allogeneic hematopoietic cell transplantation. Transplant Infectious Disease 25:S1.
Crossref
Crossref
Baogang Wang, Binwang Cao, Zhu-Chun Bei, Likun Xu, Dongna Zhang, Liangliang Zhao, Yabin Song & Hongquan Wang. (2023) Disulfide-incorporated lipid prodrugs of cidofovir: Synthesis, antiviral activity, and release mechanism. European Journal of Medicinal Chemistry 258, pages 115601.
Crossref
Crossref
Marya Y. Ornelas, Angela Y. Thomas, L. Idalee Johnson Rosas, Gisselle N. Medina & Angad P. Mehta. (2023) Characterization, Directed Evolution, and Targeting of DNA Virus-Encoded RNA Capping Enzymes Using Phenotypic Yeast Platforms. ACS Chemical Biology 18:8, pages 1808-1820.
Crossref
Crossref
Anastasy O. Kolodiazhna & Oleg I. Kolodiazhnyi. (2023) Chiral Organophosphorus Pharmaceuticals: Properties and Application. Symmetry 15:8, pages 1550.
Crossref
Crossref
Fatima Allaw, Sara F. Haddad, Johnny Zakhour & Souha S. Kanj. (2023) Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants. International Journal of Antimicrobial Agents 62:2, pages 106860.
Crossref
Crossref
Lara Dsouza, Anil Pant, Samuel Offei, Lalita Priyamvada, Blake Pope, Panayampalli S. Satheshkumar, Zhengqiang Wang & Zhilong Yang. (2023) Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts. Antiviral Research 216, pages 105651.
Crossref
Crossref
Somayeh Ghafari, Mohammad Rezaei Zadeh Rukerd, Davood Bashash, Mohsen Nakhaie, Javad Charostad, Mohammad Zarei & Azam Dehghani. (2023) Anti‐Monkeypox Infection Approaches: From Prevention to Therapeutic Lines. Clinical Pharmacology in Drug Development 12:7, pages 659-666.
Crossref
Crossref
Agam K. Rao, Caroline A. Schrodt, Faisal S. Minhaj, Michelle A. Waltenburg, Shama Cash-Goldwasser, Yon Yu, Brett W. Petersen, Christina Hutson & Inger K. Damon. (2023) Interim Clinical Treatment Considerations for Severe Manifestations of Mpox — United States, February 2023. MMWR. Morbidity and Mortality Weekly Report 72:9, pages 232-243.
Crossref
Crossref
J. P. Shabaaz Begum, Leirika Ngangom, Prabhakar Semwal, Sakshi Painuli, Rohit Sharma & Ashim Gupta. (2023) Emergence of monkeypox: a worldwide public health crisis. Human Cell 36:3, pages 877-893.
Crossref
Crossref
Gustavo Saint-Pierre Contreras, Daniel Conei Valencia, Luis Lizama, Daniela Vargas Zuñiga, Luis Fidel Avendaño Carvajal & Sandra Ampuero Llanos. (2023) An Old Acquaintance: Could Adenoviruses Be Our Next Pandemic Threat?. Viruses 15:2, pages 330.
Crossref
Crossref
Junbiao Chang & Wenquan Yu. 2023. Nucleic Acids in Medicinal Chemistry and Chemical Biology. Nucleic Acids in Medicinal Chemistry and Chemical Biology
1
40
.
Elke Lipka, Aaron M. Chadderdon, Cheryl C. Harteg, Matthew K. Doherty, Eric S. Simon, John M. Domagala, Dawn M. Reyna, Kim M. Hutchings, Xinmin Gan, Andrew D. White, Caroll B. Hartline, Emma A. Harden, Kathy A. Keith, Mark N. Prichard, Scott H. James, Rhonda D. Cardin, David I. Bernstein, Jacqueline F. Spencer, Ann E. Tollefson, William S. M. Wold & Karoly Toth. (2022) NPP-669, a Novel Broad-Spectrum Antiviral Therapeutic with Excellent Cellular Uptake, Antiviral Potency, Oral Bioavailability, Preclinical Efficacy, and a Promising Safety Margin. Molecular Pharmaceutics 20:1, pages 370-382.
Crossref
Crossref
Moslem Ghaseminia. (2023) Preventing monkeypox outbreaks: Focus on diagnosis, care, treatment, and vaccination. Journal of Clinical and Translational Science 7:1.
Crossref
Crossref
Heng Li, Qi-Zhao Huang, Hong Zhang, Zhen-Xing Liu, Xiao-Hui Chen, Li-Lin Ye & Yang Luo. (2023) The land-scape of immune response to monkeypox virus. eBioMedicine 87, pages 104424.
Crossref
Crossref
Gregory C. Gray & Dean D. Erdman. 2023. Plotkin's Vaccines. Plotkin's Vaccines
145
156.e7
.
Sameer Elsayed, Lise Bondy & William P. Hanage. (2022) Monkeypox Virus Infections in Humans. Clinical Microbiology Reviews 35:4.
Crossref
Crossref
Yong Huang, Li Mu & Wei Wang. (2022) Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Simone Cesaro & Fulvio Porta. (2022) Adenovirus Infection in Pediatric Hematopoietic Cell Transplantation: A Challenge Still Open for Survival. Journal of Clinical Medicine 11:16, pages 4827.
Crossref
Crossref
Wilfredo R Matias, Jacob M Koshy, Ellen H Nagami, Victor Kovac, Letumile R Moeng, Erica S Shenoy, David C Hooper, Lawrence C Madoff, Miriam B Barshak, Jennifer A Johnson, Christopher F Rowley, Boris Julg, Elizabeth L Hohmann & Jacob E Lazarus. (2022) Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States. Open Forum Infectious Diseases 9:8.
Crossref
Crossref
Omar M. Al-Heeti, Helen P. Cathro & Michael G. Ison. (2021) Adenovirus Infection and Transplantation. Transplantation 106:5, pages 920-927.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannPeter Lischka. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
277
296
.
Kritika Srinivasan Rajsri & Mana Rao. (2022) Poxvirus-driven human diseases and emerging therapeutics. Therapeutic Advances in Infectious Disease 9, pages 204993612211367.
Crossref
Crossref
Xinye Wang, Dawei Wang, Sajid Umar, Sheng Qin, Qiong Ling, Gregory C. Gray & Yuntao Liu. (2021) Molecular typing of human adenoviruses among hospitalized patients with respiratory tract infections in a tertiary Hospital in Guangzhou, China between 2017 and 2019. BMC Infectious Diseases 21:1.
Crossref
Crossref
Samira Karami, Elham Roshandel, Haniyeh Ghaffari Nazari, Abbas Hajifathali, Farzaneh Tavakoli & Sayeh Parkhideh. (2021) In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients. VirusDisease 32:3, pages 422-434.
Crossref
Crossref
Elke Bogner, Anna Egorova & Vadim Makarov. (2021) Small Molecules—Prospective Novel HCMV Inhibitors. Viruses 13:3, pages 474.
Crossref
Crossref
Katherine L. Seley-Radtke, Joy E. Thames & Charles D. WatersIIIIII. 2021. Coronaviruses and other Novel Antiviral Targets. Coronaviruses and other Novel Antiviral Targets
109
132
.
Arnaud G. L’Huillier & Klara M. Posfay-Barbe. 2021. Pediatric Liver Transplantation. Pediatric Liver Transplantation
164
179
.
Maricar Malinis & Marwan M. Azar. 2021. Emerging Transplant Infections. Emerging Transplant Infections
781
805
.
Mostafa A. Hussien & Ahmed E. M. Abdelaziz. (2020) Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease. Network Modeling Analysis in Health Informatics and Bioinformatics 9:1.
Crossref
Crossref
Jean-Philippe Talarmin, Schéhérazade Rezig, Adissa Tran-Minoui, Christian Berthou & Jean-Richard Eveillard. (2020) Failure of antiviral therapy with brincidofovir in non-HIV progressive multifocal leukoencephalopathy. Acta Neurologica Belgica 120:5, pages 1225-1226.
Crossref
Crossref
Kescha Kazmi, Waison Wong & Ari Bitnun. (2020) Adenovirus Infections in Immunocompetent Children. Current Infectious Disease Reports 22:10.
Crossref
Crossref
Julio J Alvarez-Cardona, Laura K Whited & Roy F Chemaly. (2020) Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiology 15:6, pages 389-400.
Crossref
Crossref
Jimin Xu, Judith Berastegui-Cabrera, Haiying Chen, Jerónimo Pachón, Jia Zhou & Javier Sánchez-Céspedes. (2020) Structure–Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection. Journal of Medicinal Chemistry 63:6, pages 3142-3160.
Crossref
Crossref
Maricar Malinis & Marwan M. Azar. 2020. Emerging Transplant Infections. Emerging Transplant Infections
1
25
.
Joshua A. Hill. (2019) Human herpesvirus 6 in transplant recipients. Current Opinion in Infectious Diseases 32:6, pages 584-590.
Crossref
Crossref
Davide Romani & Silvia Antonia Brandán. (2019) Effect of the side chain on the properties from cidofovir to brincidofovir, an experimental antiviral drug against to Ebola virus disease. Arabian Journal of Chemistry 12:8, pages 2959-2972.
Crossref
Crossref
Manuraj Singh, Helen M. Goodyear & Judith Breuer. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology
598
611
.
Diana F. Florescu & Joanna M. Schaenman. (2019) Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clinical Transplantation 33:9.
Crossref
Crossref
Diana F. Florescu & Erica J. Stohs. (2019) Approach to infection and disease due to adenoviruses in solid organ transplantation. Current Opinion in Infectious Diseases 32:4, pages 300-306.
Crossref
Crossref
Cathleen R. Carlin. (2019) New Insights to Adenovirus-Directed Innate Immunity in Respiratory Epithelial Cells. Microorganisms 7:8, pages 216.
Crossref
Crossref
Kenneth M Heidel & Cynthia S Dowd. (2019) Phosphonate prodrugs: an overview and recent advances. Future Medicinal Chemistry 11:13, pages 1625-1643.
Crossref
Crossref
William S M Wold, Ann E Tollefson, Baoling Ying, Jacqueline F Spencer & Karoly Toth. (2019) Drug development against human adenoviruses and its advancement by Syrian hamster models. FEMS Microbiology Reviews 43:4, pages 380-388.
Crossref
Crossref
Diana F. Florescu & Uriel Sandkovsky. 2019. Contemporary Pancreas and Small Bowel Transplantation. Contemporary Pancreas and Small Bowel Transplantation
343
368
.
Martin Richter. 2019. Defense Against Biological Attacks. Defense Against Biological Attacks
103
114
.
Yeon Joo Lee, Dionysios Neofytos, Seong Jin Kim, Leslie Cheteyan, Yao-Ting Huang, Esperanza B. Papadopoulos, Ann A. Jakubowski & Genovefa A. Papanicolaou. (2018) Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients. Transplant Infectious Disease 20:6, pages e12977.
Crossref
Crossref
Karoly Toth, Jacqueline F. Spencer, Baoling Ying, Ann E. Tollefson, Caroll B. Hartline, Eric T. Richard, Jiajun Fan, Jinglei Lyu, Boris A. Kashemirov, Cheryl Harteg, Dawn Reyna, Elke Lipka, Mark N. Prichard, Charles E. McKenna & William S.M. Wold. (2018) USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses. Antiviral Research 153, pages 1-9.
Crossref
Crossref
Joshua A Hill, Bryan T Mayer, Hu Xie, Wendy M Leisenring, Meei-Li Huang, Terry Stevens-Ayers, Filippo Milano, Colleen Delaney, Keith R Jerome, Danielle M Zerr, Garrett Nichols, Michael Boeckh & Joshua T Schiffer. (2018) Kinetics of Double-Stranded DNA Viremia After Allogeneic Hematopoietic Cell Transplantation. Clinical Infectious Diseases 66:3, pages 368-375.
Crossref
Crossref
Gregory C. Gray & Dean D. Erdman. 2018. Plotkin's Vaccines. Plotkin's Vaccines
121
133.e8
.
Ella J. Ariza-Heredia, Firas El Chaer & Roy F. Chemaly. 2018. Management of Infections in the Immunocompromised Host. Management of Infections in the Immunocompromised Host
317
337
.
Fatima Nazish Khan, Sahar Qazi, Khushnuma Tanveer & Khalid Raza. (2017) A review on the antagonist Ebola: A prophylactic approach. Biomedicine & Pharmacotherapy 96, pages 1513-1526.
Crossref
Crossref
Jaskaran Singh, Thapa Komal, Sandeep Arora, Amarjot Kaur & Thakur Gurjeet Singh. (2017) Ebola Hemorrhagic Fever: Recent Update On Disease Status, Current Therapies And Advances In Treatment. Journal of Pharmaceutical Technology, Research and Management 5:2, pages 217-234.
Crossref
Crossref
Donald F. Smee & Mark N. Prichard. (2017) Comparison of three dimensional synergistic analyses of percentage versus logarithmic data in antiviral studies. Antiviral Research 145, pages 1-5.
Crossref
Crossref
Sandra L. Bixler, Allen J. Duplantier & Sina Bavari. (2017) Discovering Drugs for the Treatment of Ebola Virus. Current Treatment Options in Infectious Diseases 9:3, pages 299-317.
Crossref
Crossref
Lei Cai, Yajie Sun, Yabin Song, Likun Xu, Zhuchun Bei, Dongna Zhang, Yuanyuan Dou & Hongquan Wang. (2017) Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication. Archives of Virology 162:9, pages 2847-2853.
Crossref
Crossref
Victoria Olson & Sergei Shchelkunov. (2017) Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?. Viruses 9:9, pages 242.
Crossref
Crossref
Joshua A. Hill, Bryan T. MayerHu XieWendy M. LeisenringMeei-Li HuangTerry Stevens-Ayers, Filippo MilanoColleen DelaneyMohamed L. SorrorBrenda M. SandmaierGarrett Nichols, Danielle M. Zerr, Keith R. JeromeJoshua T. Schiffer & Michael Boeckh. (2017) The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. Blood 129:16, pages 2316-2325.
Crossref
Crossref
M.A. Trad, W. Naughton, A. Yeung, L. Mazlin, M. O’sullivan, N. Gilroy, D.A. Fisher & R.L. Stuart. (2017) Ebola virus disease: An update on current prevention and management strategies. Journal of Clinical Virology 86, pages 5-13.
Crossref
Crossref
Diana F Florescu & Uriel Sandkovsky. 2017. Contemporary Small Bowel Transplantation. Contemporary Small Bowel Transplantation
1
25
.
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenOlli Ruuskanen, Jordan P. Metcalf, Matti Waris & Göran Akusjärvi. 2016. Clinical Virology. Clinical Virology
575
597
.
Peter J. ThorntonHachemi KadriAgeo MiccoliYoucef Mehellou. (2016) Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates. Journal of Medicinal Chemistry 59:23, pages 10400-10410.
Crossref
Crossref
Pauline Vetter, Julie-Anne Dayer, Manuel Schibler, Benedetta Allegranzi, Donal Brown, Alexandra Calmy, Derek Christie, Sergey Eremin, Olivier Hagon, David Henderson, Anne Iten, Edward Kelley, Frederick Marais, Babacar Ndoye, Jérôme Pugin, Hugues Robert-Nicoud, Esther Sterk, Michael Tapper, Claire-Anne Siegrist, Laurent Kaiser & Didier Pittet. (2016) The 2014–2015 Ebola outbreak in West Africa: Hands On. Antimicrobial Resistance & Infection Control 5:1.
Crossref
Crossref
Preeti Pancholi & Stanley I. Martin. 2016. Clinical Virology Manual. Clinical Virology Manual
373
385
.
Christine Robinson, Michael J. Loeffelholz & Benjamin A. Pinsky. 2016. Clinical Virology Manual. Clinical Virology Manual
255
276
.
S. Voigt, J. Hofmann, A. Edelmann, A. Sauerbrei & J.-S. Kühl. (2016) Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. Transplant Infectious Disease 18:5, pages 791-794.
Crossref
Crossref
Danielle El-Haddad, Firas El Chaer, Jackapat Vanichanan, Dimpy P. Shah, Ella J. Ariza-Heredia, Victor E. Mulanovich, Alison M. Gulbis, Elizabeth J. Shpall & Roy F. Chemaly. (2016) Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Research 134, pages 58-62.
Crossref
Crossref
D. Topalis, S. Gillemot, R. Snoeck & G. Andrei. (2016) Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase. Nucleic Acids Research, pages gkw875.
Crossref
Crossref
Jake Dunning, Stephen B. Kennedy, Annick Antierens, John Whitehead, Iza Ciglenecki, Gail Carson, Rupa Kanapathipillai, Lyndsey Castle, Rebecca Howell-Jones, Raul Pardinaz-Solis, Jennifer Grove, Janet Scott, Trudie Lang, Piero Olliaro & Peter W. Horby. (2016) Experimental Treatment of Ebola Virus Disease with Brincidofovir. PLOS ONE 11:9, pages e0162199.
Crossref
Crossref
Michael G. Ison & Randall T. Hayden. 2016. Diagnostic Microbiology of the Immunocompromised Host. Diagnostic Microbiology of the Immunocompromised Host
217
232
.
Michael G. Ison & Randall T. Hayden. (2016) Adenovirus. Microbiology Spectrum 4:4.
Crossref
Crossref
Jagadish S Jamboti. (2016) BK virus nephropathy in renal transplant recipients. Nephrology 21:8, pages 647-654.
Crossref
Crossref
Kathleen E. Simpson, Gregory A. Storch, Caroline K. Lee, Kent E. Ward, Saar Danon, Catherine M. Simon, Jeffrey W. Delaney, Alan Tong & Charles E. Canter. (2015) High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatric Cardiology 37:2, pages 399-404.
Crossref
Crossref
Stephen D. S. McCarthy, Beata Majchrzak-Kita, Trina Racine, Hannah N. Kozlowski, Darren P. Baker, Thomas Hoenen, Gary P. Kobinger, Eleanor N. Fish & Donald R. Branch. (2016) A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus. PLOS Neglected Tropical Diseases 10:1, pages e0004364.
Crossref
Crossref
D. Mondal. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Miguel J. Martínez, Abdulbaset M. Salim, Juan C. Hurtado & Paul E. Kilgore. (2015) Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infectious Diseases and Therapy 4:4, pages 365-390.
Crossref
Crossref
Anne M. Winkler & Scott A. Koepsell. (2015) The use of convalescent plasma to treat emerging infectious diseases. Current Opinion in Hematology 22:6, pages 521-526.
Crossref
Crossref
Carles Martínez-Romero & Adolfo García-Sastre. (2015) Against the clock towards new Ebola virus therapies. Virus Research 209, pages 4-10.
Crossref
Crossref
Zlatko Janeba. (2015) Development of Small-Molecule Antivirals for Ebola. Medicinal Research Reviews 35:6, pages 1175-1194.
Crossref
Crossref
Diana F. Florescu, Andre C. Kalil, Angela L. Hewlett, Amy J. Schuh, Ute Stroher, Timothy M. Uyeki & Philip W. Smith. (2015) Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease. Clinical Infectious Diseases 61:6, pages 969-973.
Crossref
Crossref
A. Mirazimi. (2015) Ebola virus disease: societal challenges and new treatments. Journal of Internal Medicine 278:3, pages 227-237.
Crossref
Crossref
Arun Kharat. (2015) Ebola Fever and Advances in the Antiviral Therapies. Journal of Human Virology & Retrovirology 2:5.
Crossref
Crossref
Trudie Lang. (2015) Ebola: Embed research in outbreak response. Nature 524:7563, pages 29-31.
Crossref
Crossref
Longhu Zhou, Hong-wang Zhang, Sijia Tao, Leda Bassit, Tony Whitaker, Tamara R. McBrayer, Maryam Ehteshami, Sheida Amiralaei, Ugo Pradere, Jong Hyun Cho, Franck Amblard, Drew Bobeck, Mervi Detorio, Steven J. Coats & Raymond F. Schinazi. (2015)
β-
d
-2′-
C
-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5′-Triphosphate Forms
. Journal of Medicinal Chemistry 58:8, pages 3445-3458.
Crossref
Crossref
Elena BekermanShirit Einav. (2015) Combating emerging viral threats. Science 348:6232, pages 282-283.
Crossref
Crossref
A. N. Reznikov, M. Yu. Skomorokhov, M. V. Leonova & Yu. N. Klimochkin. (2015) Synthesis of adamantyl-containing cidofovir analogs as potential antiviral prodrugs with high bioavailability parameters. Russian Journal of General Chemistry 85:2, pages 402-408.
Crossref
Crossref
Haoyang Li, Tianlei Ying, Fei Yu, Lu Lu & Shibo Jiang. (2015) Development of therapeutics for treatment of Ebola virus infection. Microbes and Infection 17:2, pages 109-117.
Crossref
Crossref
Kelvin K.W. To, Jasper F.W. Chan, Alan K.L. Tsang, Vincent C.C. Cheng & Kwok-Yung Yuen. (2015) Ebola virus disease: a highly fatal infectious disease reemerging in West Africa. Microbes and Infection 17:2, pages 84-97.
Crossref
Crossref
Jocelyn Yelle. (2015) The Urgent Need for Broad-Spectrum Antiviral Drugs. Journal of Human Virology & Retrovirology 2:1.
Crossref
Crossref
Nadia Litterman, Christopher Lipinski & Sean Ekins. (2015) Small molecules with antiviral activity against the Ebola virus. F1000Research 4, pages 38.
Crossref
Crossref
M. Benkő. 2015. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Paul E. Kilgore, John D. Grabenstein, Abdulbaset M. Salim & Michael Rybak. (2015) Treatment of Ebola Virus Disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:1, pages 43-53.
Crossref
Crossref